Alan C Moss, Richard J Farrell. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useColitis, Ulcerative/drug therapyHumansInfliximabRandomized Controlled Trials as Topic
Substances: See more » Antibodies, MonoclonalInfliximab
Year: 2006 PMID: 17067595 DOI: 10.1053/j.gastro.2006.09.039
Source DB: PubMed Journal: Gastroenterology ISSN: 0016-5085 Impact factor: 22.682